Rapid delivery of toxicological material
Drug Target Review
SEPTEMBER 10, 2024
However, information would be required on whether the nominated formulation would be sufficiently stable to support the rapid formulation approach and subsequent comparison to the clinical supply. Therefore, there would be almost no appetite for trying to justify a change in formulation between Tox and clinical supplies.
65 
Let's personalize your content